Phosphorylation of ataxin-3 by glycogen synthase kinase 3β at serine 256 regulates the aggregation of ataxin-3

Biochemical and Biophysical Research Communications

Volumn 357, Issue 2, 2007, Pages 487-492

  Fei, Erkang ^a   Jia, Nali ^a   Zhang, Tao ^a   Ma, Xiaochuan ^a   Wang, Hongfeng ^a   Liu, Chao ^a   Zhang, Wei ^a   Ding, Lili ^a   Nukina, Nobuyuki ^b   Wang, Guanghui ^a  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

Ataxin 3 (AT3); Glycogen synthase kinase 3 (GSK 3 ); Heat shock protein 70 (Hsp70); Machado Joseph disease (MJD); Phosphorylation

Indexed keywords

ATAXIN 1; ATAXIN 3; CHAPERONE; GLYCOGEN SYNTHASE KINASE 3BETA; HEAT SHOCK PROTEIN 70; HUNTINGTIN; POLYGLUTAMINE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MACHADO JOSEPH DISEASE; MOLECULAR WEIGHT; MUTANT; MUTATION; NONHUMAN; PATHOGENESIS; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN PHOSPHORYLATION;

BINDING SITES; CELL LINE; ENZYME ACTIVATION; GLYCOGEN SYNTHASE KINASE 3; HUMANS; KIDNEY; MULTIPROTEIN COMPLEXES; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEIN BINDING; REPRESSOR PROTEINS; SERINE;

EID: 34247160537     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.03.160     Document Type: Article

References (32)

1. Kawaguchi Y., Okamoto T., Taniwaki M., Aizawa M., Inoue M., Katayama S., Kawakami H., Nakamura S., Nishimura M., Akiguchi I., et al. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nature Genetics 8 (1994) 221-228
2. Nishiyama K., Murayama S., Goto J., Watanabe M., Hashida H., Katayama S., Nomura Y., Nakamura S., and Kanazawa I. Regional and cellular expression of the Machado-Joseph disease gene in brains of normal and affected individuals. Annals of Neurology 40 (1996) 776-781
3. Matsumoto M., Yada M., Hatakeyama S., Ishimoto H., Tanimura T., Tsuji S., Kakizuka A., Kitagawa M., and Nakayama K.I. Molecular clearance of ataxin-3 is regulated by a mammalian E4. The EMBO Journal 23 (2004) 659-669
4. Paulson H.L., Perez M.K., Trottier Y., Trojanowski J.Q., Subramony S.H., Das S.S., Vig P., Mandel J.L., Fischbeck K.H., and Pittman R.N. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron 19 (1997) 333-344
5. Kimura Y., and Kakizuka A. Polyglutamine diseases and molecular chaperones. IUBMB Life 55 (2003) 337-345
6. Jana N.R., Tanaka M., Wang G., and Nukina N. Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: their role in suppression of aggregation and cellular toxicity. Human Molecular Genetics 9 (2000) 2009-2018
7. Li F., Macfarlan T., Pittman R.N., and Chakravarti D. Ataxin-3 is a histone-binding protein with two independent transcriptional corepressor activities. The Journal of Biological Chemistry 277 (2002) 45004-45012
8. Schmidt T., Lindenberg K.S., Krebs A., Schols L., Laccone F., Herms J., Rechsteiner M., Riess O., and Landwehrmeyer G.B. Protein surveillance machinery in brains with spinocerebellar ataxia type 3: redistribution and differential recruitment of 26S proteasome subunits and chaperones to neuronal intranuclear inclusions. Annals of Neurology 51 (2002) 302-310
9. Emamian E.S., Kaytor M.D., Duvick L.A., Zu T., Tousey S.K., Zoghbi H.Y., Clark H.B., and Orr H.T. Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice. Neuron 38 (2003) 375-387
10. Chen H.K., Fernandez-Funez P., Acevedo S.F., Lam Y.C., Kaytor M.D., Fernandez M.H., Aitken A., Skoulakis E.M., Orr H.T., Botas J., and Zoghbi H.Y. Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1. Cell 113 (2003) 457-468
11. Lucas J.J., Hernandez F., Gomez-Ramos P., Moran M.A., Hen R., and Avila J. Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. The EMBO Journal 20 (2001) 27-39
12. Luo S., Vacher C., Davies J.E., and Rubinsztein D.C. Cdk5 phosphorylation of huntingtin reduces its cleavage by caspases: implications for mutant huntingtin toxicity. The Journal of Cell Biology 169 (2005) 647-656
13. Kaytor M.D., and Orr H.T. The GSK3 beta signaling cascade and neurodegenerative disease. Current Opinion in Neurobiology 12 (2002) 275-278
14. Jope R.S., and Johnson G.V. The glamour and gloom of glycogen synthase kinase-3. Trends in Biochemical Sciences 29 (2004) 95-102
15. Doble B.W., and Woodgett J.R. GSK-3: tricks of the trade for a multi-tasking kinase. Journal of Cell Science 116 (2003) 1175-1186
16. Woodgett J.R. Molecular cloning and expression of glycogen synthase kinase-3/factor A. The EMBO Journal 9 (1990) 2431-2438
17. Leroy K., and Brion J.P. Developmental expression and localization of glycogen synthase kinase-3beta in rat brain. Journal of Chemical Neuroanatomy 16 (1999) 279-293
18. Hetman M., Cavanaugh J.E., Kimelman D., and Xia Z. Role of glycogen synthase kinase-3beta in neuronal apoptosis induced by trophic withdrawal. Journal of Neuroscience 20 (2000) 2567-2574
19. Jackson G.R., Wiedau-Pazos M., Sang T.K., Wagle N., Brown C.A., Massachi S., and Geschwind D.H. Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron 34 (2002) 509-519
20. Wang G., Ide K., Nukina N., Goto J., Ichikawa Y., Uchida K., Sakamoto T., and Kanazawa I. Machado-Joseph disease gene product identified in lymphocytes and brain. Biochemical and Biophysical Research Communications 233 (1997) 476-479
21. Muchowski P.J., Schaffar G., Sittler A., Wanker E.E., Hayer-Hartl M.K., and Hartl F.U. Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils. Proceedings of the National Academy of Sciences of the United States of America 97 (2000) 7841-7846
22. Humbert S., Bryson E.A., Cordelieres F.P., Connors N.C., Datta S.R., Finkbeiner S., Greenberg M.E., and Saudou F. The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt. Developmental Cell 2 (2002) 831-837
23. Warby S.C., Chan E.Y., Metzler M., Gan L., Singaraja R.R., Crocker S.F., Robertson H.A., and Hayden M.R. Huntingtin phosphorylation on serine 421 is significantly reduced in the striatum and by polyglutamine expansion in vivo. Human Molecular Genetics 14 (2005) 1569-1577
24. Okamura-Oho Y., Miyashita T., Nagao K., Shima S., Ogata Y., Katada T., Nishina H., and Yamada M. Dentatorubral-pallidoluysian atrophy protein is phosphorylated by c-Jun NH2-terminal kinase. Human Molecular Genetics 12 (2003) 1535-1542
25. Pigino G., Morfini G., Pelsman A., Mattson M.P., Brady S.T., and Busciglio J. Alzheimer's presenilin 1 mutations impair kinesin-based axonal transport. Journal of Neuroscience 23 (2003) 4499-4508
26. Ellisdon A.M., Thomas B., and Bottomley S.P. The two-stage pathway of ataxin-3 fibrillogenesis involves a polyglutamine-independent step. The Journal of Biological Chemistry 281 (2006) 16888-16896
27. Tanaka M., Machida Y., Nishikawa Y., Akagi T., Hashikawa T., Fujisawa T., and Nukina N. Expansion of polyglutamine induces the formation of quasi-aggregate in the early stage of protein fibrillization. The Journal of Biological Chemistry 278 (2003) 34717-34724
28. Cowan K.J., Diamond M.I., and Welch W.J. Polyglutamine protein aggregation and toxicity are linked to the cellular stress response. Human Molecular Genetics 12 (2003) 1377-1391
29. Tam S., Geller R., Spiess C., and Frydman J. The chaperonin TRiC controls polyglutamine aggregation and toxicity through subunit-specific interactions. Nature Cell Biology 8 (2006) 1155-1162
30. Kitamura A., Kubota H., Pack C.G., Matsumoto G., Hirayama S., Takahashi Y., Kimura H., Kinjo M., Morimoto R.I., and Nagata K. Cytosolic chaperonin prevents polyglutamine toxicity with altering the aggregation state. Nature Cell Biology 8 (2006) 1163-1170
31. Muchowski P.J., and Wacker J.L. Modulation of neurodegeneration by molecular chaperones. Nature Reviews. Neuroscience 6 (2005) 11-22
32. Sakahira H., Breuer P., Hayer-Hartl M.K., and Hartl F.U. Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity. Proceedings of the National Academy of Sciences of the United States of America 99 Suppl. 4 (2002) 16412-16418